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Summary The c-myc nuclear associated oncoprotein has been quantitated simultaneously with DNA in
nuclei extracted from archival biopsies of uterine cervix neoplasia. The oncoprotein and DNA were measured
fluorimetrically in a flow cytometer using a mouse monoclonal antibody (MYC I-6E10) and propidium
iodide. Normal biopsies exhibited higher oncoprotein levels than carcinomas (P<0.00001). Furthermore, the
maximum fluorescence signal in the normal tissue occurred at a lower antibody concentration compared with
tumour tissue. There was no correlation between oncoprotein levels and histological grade, stage of disease,
age of the patients or prognosis in the carcinomas. Aneuploidy, defined as a distinct second peak separate
from the diploid distribution, was not a significant feature. The c-myc oncoprotein nuclear content does not
appear to be a prognostic indicator in carcinoma of the cervix from the results of these studies but there is
clearly diagnostic potential, particularly for automated analysis of cervical screening.
Oncogcincs are associated with proliferation control. The c-
sis gene encodes a subunit of platelet derived growth factor
(Doolittle et al., 1983; Waterfield et al., 1983). v-erb B and c-
fms respectively encode the intracellular domain of epidermal
growth factor receptor (Downward et al., 1984) and the
transmembrane receptor for the macrophage colony
stimulating factor, CSF 1, (Scherr et al., 1985). Expression of
the c-myc gene is associated with the transition from a
quiescent to a stimulated state (Kelly et al., 1983, 1984;
Makino et al., 1984; Greenberg & Ziff, 1984; Hann et al.,
1985; Rabbitts et al., 1985).
A series of mouse monoclonal antibodies which recognise
the c-myc nuclear associated oncoprotein, p62c-mYc, (Evan &
Hancock, 1985) have been developed (Evan et al., 1985).
One of these antibodies has been used for histological
localization of p62c-myc in both testicular cancer (Sikora
et al., 1985) and in colonic neoplasia (Stewart et al., 1986)
using immunocytochemical techniques. Quantitative methods
have now been developed to assay nuclear associated
p62cmvc in individual nuclei extracted from archival
biopsies using flow cytometry (Watson et al., 1985). These
methods have been used to analyse data in testicular cancer
(Watson et al., 1986) and colonic neoplasia (Watson et al.,
submitted). In this paper we examine the p62c-mYc nuclear
content in normal and neoplastic cervical biopsies.
Patients and methods
Patients
A total of 127 patients attending the Weston Park Hospital
Radiotherapy Department, Sheffield between 1971 and 1978
were included in the study. The only criteria of entry were
that sufficient wax embedded punch biopsy material was
available for the assay and that there were complete follow-
up data. Sixty-four biopsies were from invasive carcinoma
and 29 were from normal cervix. The remaining patients had
cervical intraepithelial neoplasia (CIN) disease where 11, 9
and 14 were grades I, II and III respectively.
Anti-p62c-mYc antibody
Full details of the methods for production of the anti-
p62c-mYc antibody are published elsewhere (Evan et al., 1985).
Briefly, synthetic peptides were constructed to hydrophilic
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domains of the amino acid structure of the protein predicted
from the DNA base sequence of the cloned gene (Niman et
al., 1983). The peptides were used as the immunogens to
produce mouse monoclonal antibodies which were purified
from ascites and adjusted to a concentration of 2mgml l.
Histological examination
Most of the biopsies from patients with carcinoma (53/64)
were examined histologically with 5gum sections cut adjacent
to the thick sections used for flow cytometry. These
contained a majority of malignant tissue which varied
between 60% and >90%. All sections contained some
normal cells. A minority of sections (10/53) contained a
distinct inflammatory cell infiltrate in necrotic areas but this
never exceeded -20% of the total cells. Sections from 18/29
normal biopsies were similarly examined. The area of
mucosa in the sections was assessed as being between -40%
(minimum) to -80% (maximum) with the remainder being
submucosal stroma. In all cases the sections contained
exclusively squamous epithelium.
Immuno-peroxidase staining
A number of 4,um sections from both normal and malignant
biopsies were stained for p62c-mYc using MYC1-6E10 in a
biotin-avidin system (Vectorstain, ABC Kit, Vector Labs) as
previously described (Stewart et al., 1986).
Flow cytometry
Extraction of nuclei and staining The wax embedded punch
biopsies were cut into 25prm sections, dewaxed then re-
hydrated. The tissue was then partially digested at 37°C in
pepsin (Sigma Ltd) at a concentration of 5mg 100ml-1 HCI
pH 1.9 for 45min (Watson et al., 1985). This is a modified
version of the method of Hedley et al. (1983) which releases
nuclei by cytoplasmic digestion. The suspension containing
nuclei was centrifuged at 200g, the supernatant was removed
and the pellet was resuspended in 6ml PBS (pH7.4) then
aliquots of 1.0ml were placed in 6 Eppendorf tubes. After a
further centrifugation the supernatants were removed and 4
pellets were resuspended in 101 of anti-p62crmYc antibody
(MYC 1-6E10) at dilutions of 1: 10, 1:31.6: 1:100 and 1:316.
Following incubation at room temperature for 45min the
samples were centrifuged and the supernatants removed. The
4 samples plus one of the controls were then incubated for
60min with 20pd fluorescein isothiocyanate conjugated
rabbit anti-mouse immunoglobulin (Dako Ltd., Denmark).
The samples were then centrifuged, the supernatants were
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removed and all samples were resuspended in 0.5ml of a
solution containing the DNA fluorochrome propidium
iodide, PI, (Calbiochem, Ltd.) and ribonuclease both at a
concentration of 0.05 mgml-1 Thus, one control contained
only PI stained nuclei, the second control contained nuclei
stained with PI and fluorescinated antibody (fluorescence
control) and the remaining 4 samples were stained with PI
plus the various MYC 1-6E10 concentrations and fluores-
cinated antibody.
Data collection and analysis The nuclei were analysed blind
for DNA and p62c-m.rY simultaneously in the Cambridge
MRC custom built dual laser flow cytometer (Watson, 1980,
1981) which incorporates a modified flow chamber to
increase light collection efficiency (Watson, 1985). The
Innova 70-5 argon ion laser (Coherent, Palo Alto, CA) was
tuned to the 488 nm line at a light power of 100 mW which
excites red fluorescence from the PI/DNA complex and
green fluorescence from the fluorescein tagged oncoprotein.
The green and red signals were separated by a 580 nm
dichroic mirror (Zeiss Ltd) and the respective photodetectors
were additionally guarded by a 515-560nm band pass filter
(green) and a 630nm long pass filter (red). Forward and 90°
light scatter were additionally collected. The instrument was
set up initially with micro beads (Polyscience Inc.,
Warrington, PA, USA) followed by cells from identically
prepared normal colonic mucosa and we have a large stock
of this from a single patient to control all experiments. This
has a GI diploid DNA peak which was routinely recorded in
channel 200 on the DNA (red) axis and at about channel 50
on the p62c-mYc (green) axis. The signal in the green channel
was due to red fluorescence breaking through the filters at
the high voltages used on the green photomultiplier. This
was an advantage as the instrument could be set up
identically for each run by using the diploid DNA peak as a
standard for both channels. The data were collected list-
mode on a fast RP07 disc via a dedicated LSI 11/23 and a
time sharing PDP 11/40 computer (all Digital Equipment
Corporation, DEC, USA) after digitization of each signal
into peak height, area and width (time of flight through the
laser beam) within the analogue-to-digital conversion (ADC)
range of 1-1024. During this series of experiments we found
that the 1024 linear ADC steps were not sufficient to
encompass the range within the biology. Hence, we initiated
electronic modifications to incorporate variable sensitivity in
the pre-amplifier circuits which increased the range to 8192.
However, this was only available for about one third of the
specimens hence, the results are presented using the 1024
range. Analysis was carried out with a VAX 8600 (DEC)
computer and the software package includes algorithms
designed to exclude clumps and debris based on pulse shape
analysis from the master triggering detector, red
fluorescence, together with light scatter signals. Full details
of this 6-dimensional procedure have been published
(Watson et al., 1985). In order to facilitate processing in the
multi-dimensional mode the data resolution was redcued
from 10-bit (1024) to 6-bit (64) precision (Watson et al.,
submitted). The median of the distribution of specific
p62C-ryc fluorescence associated with the diploid, triploid
and tetraploid regions ofthe DNA histograms were calculated
by subtracting the comparable non-specific signal recorded
from the fluorescence controls, those samples stained
with fluorescinated 2nd-antibody only.
Results
Specificity controls
Antibody specificity controls have previously been described
(Rabbitts et al., 1985; Watson et al., 1985; 1986). Briefly, 4
monoclonal antibodies which do not recognise p62c-mYc or
nuclear proteins gave no signal above background and
specific fluorescence was blocked by preincubation of
MYC 1-6E10 with the peptide used as the immunogen.
Binding of the antibody was not blocked with an irrelevant
peptide corresponding to a different region (carboxy
terminus) of the c-myc protein. A second anti-p62c-mYl
antibody (MYC-CT14) raised to the carboxy terminus amino
acid sequences has also been used in a number of related
studies as well as with some tumours reported in this paper.
The mean ratio for the MYC 1-6E10 versus the MYC-CT14
signals was 4.1 +0.36 (95% confidence limits) for 163
samples covering 5 different tumour types.
Patient data
The 12 data panels in Figure 1 each show contour plots of
signals from the green detector on the abscissa plotted
against DNA (red detector) on the ordinate from carcinoma
biopsies. The monodimensional histograms are shown
adjacent to the respective axes. The 4 columns each represent
data from a single patient where panels A, B and C
respectively show the PBS control (PI staining only), the
fluorescence control (fluorescinated 2nd antibody plus PI)
and the p62c-rYc signal (MYC 1-6E10 plus 2nd antibody and
PI). The contour display is angled away from the Y-axis in
each of the A panels due to breakthrough of the red
PI/DNA signal into the green channel. The B panels show a
small increase in the signal on the abscissa due to non-
specific trapping of the 2nd antibody; the X-axis
distributions are slightly right-shifted compared with the
respective PI controls. These data were selected and ranked
in ascending p62c-rYc levels from Cl to C4 to illustrate the
maximum range of p62c-mYc levels found in the carcinomas,
Cl being the lowest and C4 the highest.
Figure 2 shows directly comparable data from 4 normal
biopsies which have again been ordered from the lowest to
the highest p62c-mYc values, panels Cl to C4 respectively. The
majority of cells exhibited 'off-scale' p62c-mYc levels in each
panel (see X-axis histograms) in spite of reducing the
electronic sensitivity of the instrument to 25% in C3 and to
12.5% in C4.
DNA analyses
The coefficients of variation of the DNA histograms were
relatively high in this series of experiments. These varied
from 6% to 14% and all data sets were included in the
analysis irrespective of the high CVs. In only one sample was
there a well defined aneuploid component which was distinct
from the diploid peak (see Figure 1, patient 4). However,
there was a positive skew of the peak in 19 of the carcinoma
specimens which could have been due to aneuploidy, some
cells in early S-phase or to increased DNA 'stainability' in a
proportion of the population. The position of the mode of
these distributions (maximum frequency) varied between 192
and 224, representing a DNA index range of 0.96 to 1.12.
However, the medians of these same distributions were in the
range 203 to 267 giving a DNA index range of 1.01 to 1.32
with an average of 1.24. The multi-dimensional data
processing procedures used in these analyses enforced a
reduction in the data precision from 10-bits to 6-bits. Hence,
the mode of any distribution could only be recorded in
increments of 16 for the ADC range of 210. This results in a
possible error of +4% and a maximum error of 7.8% if the
true position of the diploid mode is located in channel 192.
The mean and median of the same distribution, however,
can be calculated within the range of 210 with an error of
only about +0.4% (Watson et al., submitted). However,
neither the mean nor the median is an accepted parameter
for calculating the DNA index. Due to this limitation
enforced by our current data processing procedures it would
be necessary to achieve CVs of <5% when using the modal
value to distinguish reliably between diploid and aneuploid
populations where the latter had DNA indices up to 1.32c-myc ONCOPROTEIN IN CERVICAL NEOPLASIA 277
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Figure 1 Carcinoma of cervix, DNA (ordinate) plotted as a contour map versus the signal from the green fluorescence detector
(abscissa). Columns 1 through 4 represent data from 4 patients where panels A, B and C respectively show the PBS control (PI
staining only), the fluorescence control (fluorescinated 2nd antibody plus PI) and the p62CrnYc signal (MYC 1-6E10 plus 2nd
antibody and PI). The contour display is angled away from the Y-axis in each of the A panels due to breakthrough of the red
PI/DNA signal into the green channel. The B panels show a small increase in the signal on the abscissa due to non-specific
trapping of the 2nd antibody; the X-axis distributions are slightly right-shifted compared with the respective PI controls. These
data were selected and ranked in ascending p62c-mYc levels from Cl to C4 to illustrate the maximum range ofp62c-mYc levels found
in the carcinomas, Cl being the lowest and C4 the highest.
as suggested by the median values in this series of
determinations.
Oncoprotein analysis
Because of the potential interpretive difficulties inherent in
the DNA histograms as outlined above, the medians of the
p62c-myc fluorescence distributions (in arbitrary units)
associated with only the mean of the first peak +2s.d. was
calculated at each antibody concentration. These results are
shown in Figure 3 where histograms of frequency versus
p62C-myc levels are shown for normal mucosa, CIN I, II
and III, and for carcinomas, panels A, B, C, D and E
respectively. The values given were those obtained at the
antibody concentration which gave the maximum signal. The
majority of the normal specimens were scored with values
greater than 900 and most of these were off-scale with
values in excess of 1024. The carcinomas exhibited a
bimodal distribution with the majoirity scoring below 600.
Comparisons of means for such distributions are not
particularly meaningful especially as the majority of normal
specimens gave off-scale readings. In consequence, x2 was
used as a statistical assessment by comparing the frequencies
above and below 600 in each histogram. This gave Zx2=35
with 4 degrees of freedom, P<0.00001 that the observed
distributions within the histograms could have arisen by
chance. Progression from CIN I to III was accompanied by
a shift in p62c-mYc fluorescence to lower values, x2 =4.55 with
1 degree of freedom, P<0.05. However, comparison of CIN
I with II and of CIN II with III did not reach significance at
P<0.05.
One patient had two biopsies from different regions of the
cervix. One was normal with an off-scale p62c-myc level of
1024. The second biopsy showed CIN III disease with a
p62C-mYc level of 268.
The relationships between p62c-mYc levels versus antibody
dilutions are given in Figure 4 for normal biopsies, CIN (all
grades) and for carcinomas. Histograms are shown of
frequency versus maximum p62c-myc fluorescence signal at
whichever antibody dilution the maximum occurred. This
shows that the antibody dilutions at which the maximum
signal was seen were different in normal and malignant cells.
Normal biopsies exhibited higher levels which were attained
at higher antibody dilutions. These results are analysed in
Table I which is a 3*4 frequency matrix of normal, CIN and
carcinoma versus grouped low (1: 10+ 1:31.6) and high
(1:100+ 1:316) antibody dilutions for p62c-mYc levels below
600 and greater than or equal to 600. The expected
frequencies are shown in brackets adjacent to those observed
and x2 for expected versus observed frequencies in each278 P. HENDY-IBBS et al.
Figure 2 Biopsies from normal mucosa from 4 patients where the display is directly comparable with Figure 1. Note that most
cells scored 'off-scale' for p62c-YC, see panels Cl through C4, in spite of a reduction in instrument sensitivity to 25% in C3 and to
12.5% in C4.
Table I Frequency analysis of histograms shown in Figure 4.
McAb Row
conc. p62c-myc Normal CIN Tumour totals
<600 1 (10.16) 9 (11.17) 33 (21.67)
1:10 X2 8.26 0.42 5.92
+
1:31.6 >600 5 (5.19) 6 (5.72) 11 (11.09) 22
x2 0.007 0.014 0.0007
<600 1 (4.02) 5 (4.42) 11 (8.57) 17
1:100 X2 2.27 0.076 0.678
+
1:316 >600 22 (10.63) 14 (11.69) 9 (22.67)
x2 12.16 0.456 8.25
Column totals 29 34 64 127
This is a 3 *4 matrix of normal, CIN and carcinoma versus grouped low (1:10+
1:31.6) and high (1:100+1:316) antibody dilutions for frequencies above and
below a p62c-mYc level of 600 in each histogram. The expected frequencies are in
brackets and x2 for observed versus expected frequencies is shown in each element
of the matrix. The total EX2 was 38 with 6 degrees of freedom, P<0.00001 that
these observed distributions could have arisen by chance.c-myc ONCOPROTEIN IN CERVICAL NEOPLASIA 279
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Figure 3 Medians of p62c-mYc fluorescence distributions associated
with the diploid peaks displayed as frequency histograms for
normal, CIN I, II and III and for carcinomas, panels a, b, c, d and
e respectively.
element of the matrix are given. The total Ex2 was 38 with 6
degrees of freedom, P<0.00001 that the observed
distributions in Figure 4 could have arisen by chance. Thus,
the antibody dilution which gave maximum binding was
different in normal and neoplastic cervical biopsies. CIN
occupied an intermediate position. There was no significant
correlation at P <0.05 between p62c-mY" and histological
grade, age, stage of disease or prognosis in patients with
carcinoma. However, there was a tendency, 0.05 <P <0.075,
for well differentiated carcinomas to have higher levels than
undifferentiated lesions.
Subcellular localization
Normal cervical mucosa exhibited consistent patterns of
subcellular p62C-myC localization with intense staining which
was not dependent on age. No menstrual cycle data were
available. Cells in the lower 1/3 of the mucosal layer closest
to the basement membrane showed mixed cytoplasmic and
nuclear staining but the latter predominated. In the upper
2/3 of the mucosa the cytoplasmic staining predominated
with increasing distance from the basement membrane, but
nuclear staining continued to be observed. Stromal cells
showed very weak staining. The carcinomas exhibited
generally weak staining with large areas in all sections
showing very little or no staining. However, focal areas were
present in all sections in which both nuclear and cytoplasmic
staining was observed. In some of these areas in well
differentiated tumours the staining was almost as intense as
in normal mucosa. There was no discernible pattern to the
patchy focal staining in the carcinomas with no apparent
relationship to necrotic areas or vacularity.
Discussion
The significant finding in this investigation was a progressive
decrease in the median of the p62c-mYc fluorescence
distributions, assayed by the MYC 1-6E10 antibody in
archival cervical nuclei, with progression from normal to
neoplastic biopsies. Furthermore, these differences are
probably underestimated as all normal specimens contained
some stromal cells which showed very weak staining. This
finding was not expected, particularly as Riou et al. (1984)
have reported c-myc gene amplification in over 50% of stage
3 and 4 patients with cervical carcinoma in a small study.
Our initial expectation was based on the preconception that
disordered proliferation control might be related to an
increased expression of the protein in neoplastic cells.
However, the function of p62c-myc is not yet understood and
we cannot ascribe any functional significance to either our
findings or our preconceptions at present. Nevertheless, a
number of possibilities exist for the divergence from
expectation including post-translational protein modification
or c-myc gene mutation in malignant cells, increased
turnover of the protein which is known to have a short half-
life in stimulated cells (Hann et al., 1985; Rabbitts et al.,
1985) and a possible increase in the susceptibility of the
protein to proteolysis in neoplastic cells in the prepatation
for the assay. Further factors to be considered include
greater accessibility of p62c-myc in normal cells and the
possibility that the MYC 1-6E10 antibody recognises an
epitope of some other nuclear associated protein(s). The
specificity controls, including the blocking assays, do not
positively exclude the last possibility. However, in 163
tumours from 5 different malignancies, including some
tumours from this study, there was a 4.1:1 direct
relationship between results with MYC 1-6E10 and an
antibody (MYC-CT14) which recognises a different region of
the protein, the carboxy terminus. It is unlikely that both
antibodies would recognise epitopes on different proteins on
a quantitative basis. Furthermore, in studies with fresh
colonic mucosa and carcinomas there was good correlation
between p62c-mYc mRNA and Western blotting (Sikora et al.,
1987) with results from flow cytometry (Watson et al.,
submitted) using the same technique as reported in this
paper.
Somewhat similar results to those given here were
obtained in teratoma biopsies where undifferentiated lesions
had lower p62c-myc levels compared with well differentiated
tumours showing yolk sac elements (Watson et al., 1986).
Moreover, in the present study we have shown that the
antibody concentrations at which the maximum fluorescence
response occurred were different in normal and malignant
cells and it may be significant that the MYC 1-6E10
antibody was raised to peptide sequences corresponding to
the normal gene. The data in Figure 4 suggest that there
may be different protein binding constants for this antibody
in normal and malignant cells and an altered protein
structure could be implicated. However, these fundamental
questions which relate to function are not likely to be
resolved with nuclei extracted from wax embedded biopsies.
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Many oncogene encoded proteins are associated with the
transduction and transmission of mitotic stimuli and the
scenario of a well ordered and integrated molecular chain
controlling proliferation is beginning to emerge. Thus far, c-
sis (Doolittle et al., 1983: Waterfield et al., 1983) encodes an
extracellular transmitter (PDGF), v-erb B (Downward et al.,
1984) and c-fms (Scherr, et al., 1985) respectively encode the
intracellular domain of epidermal growth factor receptor and
the transmembrane receptor for macrophage colony
stimulating factor (CSF-1). Recently it has been suggested
that p21IN-ras links the effects of growth factor stimulation
with increased phosphoinositol turnover and hence may act
as an intracellular transmitter (Wakelam et al., 1986). The
final links in this molecular chain reside in the nucleus and
oestrogen receptor, now known to be a nuclear protein with
some biochemical properties not dissimilar to those of
p62c-mrYc, is encoded by v-erb A (Green et al., 1986). p62c-mYc
is also known to be nuclear associated, and it elutes from
the nucleus at salt concentrations as low as 200mM (Evan &
Hancock, 1985). This is within the intracellular physiological
range and suggests a possible role as a DNA binding protein
functioning in proliferation control in response to ionic
changes associated with mitotic stimulation.
In spite of its nuclear location in tissue culture cells (Evan
& Hancock, 1985) there are circumstances where p62c-mYc has
been observed in the cytoplasm. Using immunoperoxidase
staining in formalin fixed archival normal colonic mucosa
the protein was present in both the nucleus and cytoplasm
with the most intense staining observed in the middle 1/3 of
the crypts of Lieberkuhn (Stewart et al., 1986). In testicular
cancer studies we found intense nuclear and cytoplasmic
staining in well differentiated yolk sac elements (Sikora et
al., 1985). In further studies in colonic mucosa we have
observed similar patterns in freshly fixed tissue with p62c-mYc
showing weak but exclusively nuclear staining in the crypt
bases. In the middle 1/3 it was located, and intensely stained,
in both nucleus and cytoplasm. However, at the crypt
surface the protein had become completely redistributed with
cytoplasmic staining predominating (Forcacs et al., 1986).
Previously, we thought that the cytoplasmic staining could
have been an artefact due to the fixation and preparative
processes (Stewart et al., 1986) but this now seems
increasingly unlikely as the same phenomenon has been
observed repeatedly in colonic tissue freshly fixed with 50%
methanol under isotonic conditions. Similar patterns were
seen in the immunoperoxidase stained normal cervical
sections in this study where cytoplasmic staining
predominated with increasing maturation towards the
surface of the mucosa. Relocation of the protein in the
cytoplasm with exclusion from the nucleus could, therefore,
be involved in the maturation and differentiation process.
The quality of some of the DNA histograms was not good
in this series of experiments. This was not due to the
relatively thin sections (25pm) used in the determinations as
the pulse shape algorithms in the software package exclude
nuclear fragments, debris and clumps. These routines predict
a decreasing proportion of intact nuclei conforming to a
given pulse shape pattern with decreasing section thickness
(Watson, et al., 1985). All carcinoma sections examined
histologically (53/64) contained some cells with normal
morphology hence, we expected to see two peaks in any
aneuploid tumours. This was seen in only one tumour
(Figure 1, C4), but there was a positive skew to the DNA
peak in 30% of specimens which was probably due to
aneuploid components. Nevertheless, in spite of our failure
to clearly resolve these presumed aneuploid components
there was a very clear statistical difference between the
normal biopsy and the invasive carcinoma groups based on
p62C-MYc levels. All the data shown in Figure 3 and 4 were
associated with the first peak of the DNA histograms.
However, one of the patients included in the normal
category had chronic interstitial cervicitis and the p62c-mYc
level in this specimen was low at 147. All the carcinoma
specimens recorded with median p62c-mYc values greater than
600 contained a substantial number of cells with very low
fluorescence levels, less than 300. In contrast, apart from the
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single patient with chronic interstitial cervicitis, there was no
specimen in the normal group where more than about 10%
of the population scored below 300.
At present the dynamic range of our instrument is still
insufficiently large to encompass the biological differences
observed in spite of the introduction of variable sensitivity
during these studies which increased the range to 8 K. This is
being rectified by the introduction of variable neutral density
filters which together with variable preamplifier gain will
increase the dynamic range to 320 K.
Although p62C-mYc does not appear to give prognostic
information in carcinoma of the cervix it may provide a
diagnostic marker which is potentially more important. We
have recently developed methods using the Cyto-Brush
(Medscand, Malmo, Sweden) to collect cervical epithelium
for this assay on a routine bases from colposcopy clinics
(Elias-Jones et al., 1986). The cell yield was good and was
not contaminated with stromal cells which is another
potential artefact source in punch biopsy material.
Specimens collected with the Cyto-Brush are perfectly
suitable for both cytological and flow cytometric analysis
after methanol fixation and can be mailed with the potential
for automated prescreening. A number of such procedures
have been developed using both flow and microscope based
image analysis systems. These include slit-scan nuclear cyto-
plasmic ratios (Wheeless et al., 1984), measurement of DNA
content (Tsou et al., 1984; Fujii et al., 1984; Barrett et al.,
1979; Tucker, 1979; Sprenger & Witte, 1979), DNA content
plus total protein (Linden et al., 1979) and image analysis
assaying DNA and chromatin 'texture' (Al & Ploem, 1979;
Smeulders et al., 1979). These methods are based on either
morphology or non-specific biochemical markers (DNA and
total protein). This may not always be sufficient to make a
reliable distinction as morphology, DNA content and
chromatin 'texture' need not reflect the malignant phenotype.
Our methods are being directed towards biochemical assays
in normal and malignant cells which may reflect either
qualitative or quantitative differences in specific proteins
which are thought to play a part in growth regulation and
proliferation control. The c-myc gene product is one such
protein (Hann et al., 1985; Kelly et al., 1983, 1984; Makino
et al., 1984; Rabbitts et al., 1985) and combinations of this
technique with some of those mentioned above will un-
doubtedly result in more accurate automated screening
procedures.
WethankDrJohnGoepel,WestonParkHospital,Sheffieldforproviding
the biopsy specimens.
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